Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk
Claire E Wakefield, Bettina Meiser, Judi Homewood, Robyn Ward, Sheridan O'Donnell, Judy Kirk
CANCER | WILEY | Published : 2008
BACKGROUND: Despite the potential benefits of genetic testing for hereditary nonpolyposis colorectal cancer (HNPCC) risk, individuals can find the genetic testing decision-making process complicated and challenging. The goal of the current study was to measure the effectiveness of a tailored decision aid designed specifically to assist individuals to make informed decisions regarding genetic testing for HNPCC risk. METHODS: In all, 153 individuals were randomized to receive the decision aid or a control pamphlet at the end of their first genetic counseling consultation. Of these, 109 (71.2%) completed the first questionnaire 1 week after consultation, whereas 95 (62.1%) completed the 6-month..View full abstract
Awarded by Cancer Council of New South Wales
Funded by the Cancer Council of New South Wales (Project Grant 300441).